La tirzepatida es un medicamento inyectable utilizado para el tratamiento de la diabetes mellitus tipo 2 y el manejo del sobrepeso y la obesidad en adultos
Br J Pharmacol 177(3):656667
It turned out to be possible to go beyond the traditional use of GLP-1 and GLP-1RAs for the treatment of T2DM, metabolic syndrome, and obesity, since these compounds affect the liver, pancreas, brain, fat cells, heart, and gastrointestinal tract [107]
The moment she was diagnosed with advanced renal disease I started to give her Subcutaneous fluids which helped with the effects of the disease immensely
They can also opt to decrease it temporarily if necessary
Wegovy remains on the list